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Data Adaptive Pathway Testing
Merrill D. Birkner, Alan E. Hubbard, and Mark J. van der Laan
Abstract
A majority of diseases are caused by a combination of factors, for example, com-
posite genetic mutation profiles have been found in many cases to predict a dele-
terious outcome. There are several statistical techniques that have been used to
analyze these types of biological data. This article implements a general strategy
which uses data adaptive regression methods to build a specific pathway model,
thus predicting a disease outcome by a combination of biological factors and as-
sesses the significance of this model, or pathway, by using a permutation based
null distribution. We also provide several simulation comparisons with other tech-
niques. In addition, this method is applied in several different ways to an HIV-1
dataset in order to assess the potential biological pathways in the data.
1 Introduction
1.1 Motivation
A majority of diseases are caused by a combination of factors, for example,
composite genetic mutation proﬁles have been shown in many cases to predict
disease. This is especially relevant to genetically caused diseases, where one
mutation alone does not cause a deleterious state, but instead several muta-
tions in combination will cause a speciﬁc disease outcome. Speciﬁc cancers,
for example, may be inﬂuenced by the accumulation of and interactions be-
tween genetic mutations. Therefore determining these speciﬁc genetic models
is vital when predicting the cancerous state of an individual.
Scientists are posed with the problem of determining the speciﬁc com-
bination of factors which predicts an outcome, and the respective overall
signiﬁcance of a model. In order to predict a speciﬁc outcome based on a
combination of variables, several methods have been proposed in the sta-
tistical literature. This article will outline an existing approach which will
determine the signiﬁcance of the association of a pathway (subset of biologi-
cally relevant factors) with an outcome. This technique will be compared to
other methods in simulations. Additionally, the pathway procedure will be
applied to an HIV-1 dataset. The method will be used to predict the viral
replication from sets of codons.
1.2 Current Statistical Approaches
Several methods have been used to test biological pathways. This section will
brieﬂy outline the current procedures. Firstly, a speciﬁc pathway technique
was proposed by Jelle Goeman to model these biological processes. This
procedure is implemented in R and is referred to as globaltest(). The goal
of this procedure is to test if a group of factors is associated with a given
outcome. Therefore, in a situation with M genes, one is interested in testing
a subgroup of these genes. The test will give one signiﬁcance level, or p-value
for each group of genes. One can therefore determine if a gene expression
pattern is related to a speciﬁc clinical outcome (continuous or categorical).
This approach is based on the following model setup: E(Yi|ri) = h−1(α+ri),
where ri =
∑
j xijβj for i = 1, ..., n. They describe this model as a random
eﬀects model in which each individual inﬂuences the outcome. The vector
r = r1, ...rn has E(r) = 0 and Cov(r) = τ
2XXT . In order to test the null
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hypothesis, τ 2 = 0, a score test statistic is calculated and compared to a cX2
distribution with a speciﬁc scaling factor, c. When the user is performing
this pathway test on a small sample, there is an option in the function to
implement the permutation method to calculate a respective p-value. The
global pathway technique has also been extended to the case of a survival
outcome (Goeman et al., 2005). In this case the clinical outcome is the
survival of a patient. Again one is interested in determining subgroups, or
pathways, of genes that predict survival.
In addition to the global test procedure, researchers can also use uni-
variate tests of the variables in the model or pathway to test the relative
signiﬁcance of the entire pathway. These tests are then adjusted for multiple
testing, since one or more repetition implies repetition of the null hypothesis
of interest. This technique involves initially creating univariate tests of each
gene in a subgroup. A multiple testing approach controlling family wise error
(FWER) is then applied to the group of tests. A pathway is in turn declared
signiﬁcant if at least one of the variables has a adjusted p-value, adjusting
for multiple testing, less than a pre-speciﬁed α level. This procedure does
not inherently include interaction terms among the various genes.
The article will focus on a method which constructs a permutation null
distribution for the test statistic of the model. As expanded upon in the
subsequent sections, a data adaptive technique will be used to build the
model. A similar method consists of performing a linear regression with
the biological factors. This therefore assumes that these variables (X =
X1, ...Xp) are main eﬀect terms, and does not incorporate the inclusion of a
biological interaction between two or more factors. In addition, this method
does not allow for a non-linear function of an individual factor. Such an
approach is adequate if the model does not contain an interaction or if it
is of a linear form, but models deviating from this form are not correctly
modelled with this technique. Thus, this approach could lack power to detect
a signiﬁcant association if the true model deviates signiﬁcantly from linear.
A special case of the method described in this paper is included as an
option in the logic regression R function to test the signiﬁcance of the model
against the null model (Ruckinski et al., 2003). The logic regression method
uses a data adaptive regression technique to build Boolean combinations of
binary covariates. This regression technique allows main eﬀect terms as well
as interactions to be included in the model when predicting an outcome. The
logic regression method includes an option referred to as the ”null model
test” (Ruckinski et al., 2003). This is a test for signal in the data and
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compares the optimal logic model to the null model, which is based on the
permutation distribution. The null hypothesis which is tested corresponds
to independence between the dependent and independent variables. The
model is built on a dataset corresponding to the original covariates and a
permuted set of outcome variables. Each model produces a score and the
proportion of model scores under this null model which exceed the optimal
model corresponds to the p-value of the optimal model. This is implemented
in the R function logreg() in the LogicReg library (Ruckinski et al., 2003).
To the best of our knowledge the application of the permutation based null
distribution and data adaptive regression is only used in Logic Regression,
and has not been widely advertised as a method to test the signiﬁcance of
a model built by a data adaptive regression technique. Our purpose is to
generalize this approach and add a formal argument to why this approach
gives exact inference.
2 Methods
2.1 Data Adaptive Approach
We denote the data as (Yi, Xi), where i = 1, ..., n. The outcome measure is
Yi and the covariates of interest is a vector Xi for each individual i. We wish
to test the null hypothesis: H0 : X ⊥ Y . In order to determine the optimal
model which best predicts the outcome from a group of variables, a data
adaptive regression technique will be implemented. Data adaptive regression
procedures use selection criteria to choose the variables and forms of variables
to place in the model, including in some cases, linear spline terms. The
pathway method outlined in this article can use any data adaptive procedure,
but for the sake of the simulation example, we illustrate the polyclass()
method in R (Kooperberg et al., 1997).
POLYCLASS is an exploratory, data-adaptive, or black box regression
technique used to predict categorical or binary outcomes. This classiﬁcation
method, uses forward addition and backward deletion, searches through a
series of models deﬁned by main eﬀects, splines and cross-products to create
a logistic regression model. The procedure uses cross-validation to choose the
complexity (number of basis functions) of the model. With respect to the
addition steps, proposed new predictors are either main eﬀects not already
in the model; knots to existing main eﬀects creating linear spline terms or;
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any interaction terms already in the model. For the deletion step, terms are
removed hierarchically (e.g., a main eﬀect term is not removed before it’s
corresponding interaction term).
An alternative method to the polyclass() function is the deletion, sub-
stitution, and addition algorithm, proposed by Sinisi and van der Laan
(2004). The Cross-validated Deletion/Substitution/Addition (D/S/A) al-
gorithm (Sinisi and van der Laan, 2004) is a data-adaptive machine learning
methodology, which is used to predict an outcome or response, Y , given a
set of covariates. The algorithm minimizes the expectation of a speciﬁc loss
function. In the case of a continuous outcome, the loss function is the resid-
ual sum of squares and the parameter of interest is the expectation of the
outcome given the covariates. The algorithm is based on deletion, substi-
tution, and addition moves which build models of varying dimensions. The
ﬁnal model is chosen as the model that minimizes the cross validated resid-
ual sum of squares. Finally, other data adaptive techniques include logic
regression or MARS (Ruckinski et al., 2003; Friedman, 1991).
2.2 Summary Statistic
Once a model is built using a data adaptive regression technique a summary
statistic of this model is computed. This summary statistic compares the
built model to the model including only the intercept. In the case of a logistic
regression model, we will use the likelihood ratio statistic, 2∗log(LR0−LR1).
The tail probability (p-value) of this summary statistic is then computed
under a X2 distribution with the degrees of freedom equaling the diﬀerence in
the number of parameters between the full and null model. We will estimate
the null distribution of the p-value using a permutation approach.
2.3 Permutation Null Distribution
After obtaining the reference p-value from the summary statistic of the pro-
posed model, the relative signiﬁcance of this p-value in comparison to the null
distribution must be calculated. The method will revolve around the con-
struction of the null distribution, for which the null hypothesis, H0 : Y ⊥ X,
holds. The permutation distribution can be shown to provide correct error
control under the null hypothesis in the following manner: If the null hypoth-
esis is true, and therefore Y ⊥ X, then the conditional distribution of the
data given the marginal empirical distributions of (X1, ..., Xn), (Y1, ..., Yn)
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of X and Y , respectively, equals the permutation distribution. Therefore
controlling the Type-I error under the permutation distribution corresponds
with controlling the Type I error under the true conditional distribution if
H0 is true. In particular, this shows that if H0 is true, then the Type I er-
ror control under the permutation distribution implies Type I error control
under the true distribution.
In order to create this null distribution, the outcome values are permuted,
therefore corresponding to the situation where there is no association be-
tween the dependent and independent variables. The data is permuted and
the polyclass() function is applied to the data and a model is built using
the same data adaptive technique. The p-value from the likelihood ratio
summary statistic is computed, by comparing it to a speciﬁc X2 distribu-
tion. This permutation method is repeated for each unique permutation of
the data (or a practical number of times, e.g. 5000) and a distribution of
p-values is calculated. The p-value of the overall association of the outcome
and the risk factors is simply the survival function of the observed p-value in
the original experimental dataset, with respect to the permutation distribu-
tion: The pathway p-value= Sperm(pˆ) ≡ P (X ≥ pˆ), where X’s distribution
under the null is the permutation distribution.
3 Simulations
3.1 Type I error rate
Before applying this method to biological datasets, we must determine the
Type-I error control of this method. In order to determine this control, we
simulated data in which the outcome was independent of the covariates. We
simulated an outcome from a Binomial distribution with probability equal
to 0.5. There were M = 20 covariates, X = X1, ...X20, which were simulated
from a Multivariate Normal distribution with mean 0 and correlation matrix
of 0.8 between all variables, and 1 between the diagonal elements. The sample
sizes studied included n = 200, 500, 700.
We simulated 500 datasets, each using 3000 unique permutations for the
creation of the null distribution; the null distribution was the permutation
data null distribution.
Table 1 indicates that this method has the correct Type-I error control
(the probability of rejecting the null is at the speciﬁed α-level). This therefore
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Table 1: Type-I Error Control.
Simulation Parameters Type-I error (out of 500 iterations)
Y ∼ B(p = 0.5), X ∼ mvn(0,Σ = 0.8), n = 200,M = 20 0.044
Y ∼ B(p = 0.5), X ∼ mvn(0,Σ = 0.8), n = 500,M = 20 0.052
Y ∼ B(p = 0.5), X ∼ mvn(0,Σ = 0.8), n = 700,M = 20 0.048
indicates that the procedure has correct error control in correctly accepting
models in which the Y is independent of the X covariates.
Testing methods attempt to control Type I error rate while simultane-
ously maximizing power of the procedure. This previous section indicated
that this procedure seems to have proper control over 500 simulated datasets.
Simulations are now presented which were performed to determine the
power of the procedure in various scenarios. The simulations included a
binary outcome Y (derived from an underlying model), n = 500, and i ∼
N(0, 1) error terms was added to the linear term when constructing the
probability. Therefore, when p is equal to the number of covariates in the
model, the probability can be written as:
P (Y = 1|X) = e
(β0+β1X1+...βpXp+)
1 + e(β0+β1X1+...βpXp+)
. (1)
The ﬁrst dataset was created with M = 10 terms, or covariates, and
and underlying model of logit(P ) = β0 + β1X1X2 + , with β0 = 5.179, and
β1 = 5.154. Therefore, the model used to construct the probability of Y = 1
was:
P (Y = 1|X) = e
(β0+β1X1X2+)
1 + e(β0+β1X1X2+)
. (2)
In addition to the polyclass pathway technique, the regression method
with main eﬀects, Golubtest, and the FWER technique were compared. Both
the Polyclass method as well as the Logistic Regression, Backward and For-
ward and Backward regression used the permutation distribution. The Re-
gression X1 + X2 method consists of testing a logistic regression with two
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Table 2: Comparison of Methods
Method Power (rejections/500 iterations)
Polyclass 0.762
Logistic Regression, X1 + X2 0.204
Golubtest (Pathway 1:2) 0.18
Logistic Regression, 10 main terms 0.12
Logistic Forward and Backward Selection 0.15
Logistic Backward Selection 0.10
FWER 0.062
main eﬀect terms. Golubtest (Pathway 1:2) also used X1 and X2. The re-
gression with 10 main terms tested a logistic regression with each of the 10
Xs as a main eﬀect term. The forward and backward selection and forward
selection methods were separately applied to the logistic model with 10 main
eﬀect terms. Finally, the FWER technique applied the Bonferroni adjust-
ment to univariate tests of each of the 10 variables on the outcome. If any
of these 10 adjusted p-values were less than 0.05 the pathway was claimed
signiﬁcant.
Table 2 indicates that given an interaction term in the model, the poly-
class model is most eﬃcient at picking up a model and claiming it signiﬁcant.
The models assuming either all main terms, a limited number of main terms,
or various types of selection or multiple testing are not optimal, with respect
to power, given the underlying model.
We next simulated data from an underlying model where the truth was
X2 where β0 = 1.179, β1 = 2.154, and i ∼ N(0, 1) (we put in an additional
error term so that the true model is not a simple logistic regression). This
can be written as follows:
P (Y = 1|X) = e
(β0+β1X21+)
1 + e(β0+β1X
2
1+)
. (3)
The Xs were drawn from either a normal or exponential distribution.
When the X1’s are N(0, 1) the resulting logit function over the observed
X1’s is concave in X1, when the X1’s are exponential (λ = 1), the function
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Table 3: Truth is X21 :
Truth/Method α Power (rejections/500 iterations)
Polyclass (Normal) 0.05 0.220
Polyclass (Normal) 0.10 0.270
Polyclass (Exponential) 0.05 1
Polyclass (Exponential) 0.10 1
Logistic Regression (Normal) 0.05 0.01
Logistic Regression (Normal) 0.10 0.02
Logistic Regression (Exponential) 0.05 1
Logistic Regression (Exponential) 0.10 1
is nearly linear in X1. The polyclass method was applied to the data to
determine the respective power, as well as a method that builds a logistic
regression with X1 as its only main eﬀect term.
These simulations (Table 3) indicate that in the case of exponential X
values both the polyclass and logistic model pick up the desired model. The
logistic model technique seems to be approximating the exponential shape
with a line which is adequate in this situation. In the case where the Xs come
from a normal distribution, the logistic model has a diﬃcult time picking up
this model, and polyclass does provide an improvement, although other black
box regression techniques could do a better job of predicting this quadratic
curve.
Finally, Table 4 compares the two methods when the truth was merely
one X variable. Again, in the case of a regression, a logistic regression was
ﬁt with X2 as its only main eﬀect term. The underlying model is logit(P ) =
β0 + β1X2, where β0 = 0.179, β1 = 0.154, and the errors of the linear term
were i ∼ N(0, 1). The 10 X variables originated from N(0, 1) distribution.
In this case, the regression technique seems to outperform the polyclass
technique. Both procedures are using the permutation null distribution, but
with only one variable, the main eﬀect regression technique could be produc-
ing a simpler model as compared to the polyclass technique, thus resulting
in higher power.
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Table 4: Truth is X2:
Truth/Method Power (rejections/500 iterations)
Polyclass 0.086
Logistic Regression 0.284
4 Data Analysis
Throughout this section we will refer to an application to an HIV-1 dataset.
The described method was applied in a variety of ways to this dataset. The
subsequent sections will initially outline the dataset and discuss the various
applications of the pathway technique. All of these techniques resulted in
ﬁndings which parallel previous statistical and biological ﬁndings.
4.1 HIV-1 Dataset
Studying the sequence of the Human Immunodeﬁciency Virus Type 1 (HIV-
1) genome could potentially give important insight into the genotype–phenotype
associations of the virus and in turn for the Acquired Immune Deﬁciency
Syndrome (AIDS).
The phenotype which is studied in this dataset is the replication capac-
ity (RC) of HIV-1, as it reﬂects the severity of the disease. A measure of
replication capacity may be obtained by monitoring viral replication in an
ideal environment, with many cellular targets, no exogenous or endogenous
inhibitors, and no immune system responses against the virus (Barbour et al.,
2002; Segal et al., 2004).
The genotypes correspond to codons in the protease and reverse tran-
scriptase regions of the viral strand. The protease (PR) enzyme aﬀects the
reproductive cycle of the virus by breaking protein peptide bonds during
viral replication. The reverse transcriptase (RT) enzyme synthesizes double-
stranded DNA from the virus’ single-stranded RNA genome, hence facili-
tating integration of the virus’ genetic material into the host’s chromosome.
Since the PR and RT regions are essential to viral replication, many an-
tiretrovirals (protease inhibitors and reverse transcriptase inhibitors) have
been developed to target these speciﬁc genomic locations. Studying PR and
RT genotypic variation involves sequencing the corresponding HIV-1 genome
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regions and determining the amino acids encoded by each codon (i.e., a codon
corresponds to a group of three nucleotides).
The HIV-1 sequence dataset consists of n = 317 records, linking viral
replication capacity (RC) with protease (PR) and reverse transcriptase (RT)
sequence data, from individuals participating in studies at the San Francisco
General Hospital and Gladstone Institute of Virology (Segal et al., 2004).
Protease codon positions pr4 – pr99 and reverse transcriptase codon positions
rt38 – rt223 of the viral strand are studied in this analysis.
The outcome/phenotype of interest is the natural logarithm of a con-
tinuous measure of replication capacity, ranging from 0.261 to 151. The
282 covariates correspond to the codon positions in the PR and RT regions,
with the number of possible codons ranging from one to ten at any given
location. A majority of patients typically exhibit one amino acid at each
position. Codons are therefore recoded as binary covariates, with value of
zero corresponding to the most common amino acid among the n = 317
patients and value of one for all other amino acids, thus corresponding to
a mutation. Previous biological research was used to conﬁrm mutations
and hence provide accurate PR and RT codon genotypes for each patient.
The data for each of the n = 317 patients therefore consist of a replica-
tion capacity outcome/phenotype Y and an 282–dimensional covariate vec-
tor X = (X(m) : m = 1, . . . ,M) of binary codon genotypes in the PR and
RT HIV-1 regions.
4.2 Testing a Single Pathway
The initial data analysis which was applied to the HIV-1 dataset consisted of
testing a subset of codons against the outcome of replication capacity. The
subset of codons consisted of those mutations in the protease and reverse
transcriptase positions which are known from the literature to be predictive
of a change in replication of the virus. A detailed review of these positions
can be found in Birkner et al. (2005). These positions consisted of: rt184,
rt215, rt41, rt210, rt116, rt65, rt67, rt69, rt70, pr54, pr53, pr46, pr47, pr48,
pr50, pr36, pr77, pr82, pr32, pr84, pr20, pr30, pr24, pr73, pr88, pr10, pr90,
pr93, pr71, pr63.
In the applications with the HIV-1 dataset, the data adaptive method
which was used to build the models was polymars() in the R library(polspline).
This method is similar to the polyclass method with the exception that it is
adapted to continuous outcomes, whereas the polyclass method is based on
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the logit function and therefore adapted to binary or categorical outcomes.
The function polymars is an adaptive regression procedure which uses lin-
ear splines to model the response. Therefore this method examines all main
eﬀects, interactions and splines to model the outcome by a set of predictor
variables.
The pathway analysis was performed with the outcome Yi, i = 1, ..., n
corresponding to the n = 317 replication capacity values. The M = 30
codon positions listed above corresponded to X matrix, which is of dimension
n × M . The polymars data adaptive regression function resulted in the
following model corresponding to the prediction of replication capacity by a
set of covariates:
ln(RC) = 3.598− 3.261(pr32)− 0.542(rt184) + 0.369(pr47) (4)
The summary statistic of this model was the F-statistic and a respective
tail probability (p-value) was obtained by comparing this statistic to the F-
distribution. This model was tested against the null hypothesis, in which
the replication capacity is independent of the covariates. The n replication
capacity values were permuted and the polymars() model was subsequently
run. This was repeated 5000 times, each time a resulting p-value of the
summary F-statistic was recorded. The corresponding p-value of the above
model was compared to these 5000 p-values to determine its signiﬁcance as
compared to the null distribution. The ﬁnal p-value for the above model was
0.0001, therefore indicating the signiﬁcance of this model. Biological results
of the individual codons in this model will be further discussed below.
4.3 Testing Multiple Pathways
In addition to testing a single pathway in the HIV-1 virus, it is also interesting
to test the spatial signiﬁcance of groups of codons. Therefore, in this example,
one is only interested in the linear form of the virus, thus ignoring spatial
interactions. Starting at the ﬁrst codon, pr4, non-overlapping groups of 6
codons are tested separately against the outcome of replication capacity.
In total there are 282 positions, and considering neighboring groups of 6
codons, there will be 47 groups. For example, the pathway method will be
applied to pr4, pr5, pr6, pr7, and pr8, and a p-value will be recorded, which
compares this model to the null distribution. The procedure is identical to
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Table 5: 15 Most Signiﬁcant Codon Groups
Codons p-value
pr10, pr11, pr12, pr13, pr14, pr15 0.0001
pr28, pr29, pr30, pr31, pr32, pr33 0.0001
pr34, pr35, pr36, pr37, pr38, pr39 0.0001
pr40, pr41, pr42, pr43, pr44, pr45 0.0001
pr46, pr47, pr48, pr49, pr50, pr51 0.0001
pr52, pr53, pr54, pr55, pr56, pr57 0.0001
pr70, pr71, pr72, pr73, pr74, pr75 0.02
pr82, pr83, pr84, pr85, pr86, pr87 0.01
pr88, pr89, pr90, pr91, pr92, pr93 0.0001
rt38, rt39, rt40, rt41, rt42, rt43 0.01
rt98, rt99, rt100, rt101, rt102, rt103 0.045
rt116, rt117, rt118, rt119, rt120, rt121 0.0001
rt134, rt135, rt136, rt137, rt138, rt139 0.035
rt182, rt183, rt184, rt185, rt186, rt187 0.0001
rt212, rt213, rt214, rt215, rt216, rt217 0.01
the procedure described above in which a model is ﬁt using polymars and the
p-value corresponding to the summary F-statistic is recorded. This p-value
is compared to a distribution of p-values obtained by running polymars on a
permuted dataset 5000 times. Subsequently, pr9, pr10, pr11, pr12, and pr13
will be tested, and so on. This testing procedure will allow one to examine
the spatial signiﬁcance of the codons. The ﬁnal 47 respective p-values will
be plotted to examined.
The results of this analysis are presented in Figure 1 and Figure 3. Figure
3 illustrates a linear schematic of the virus and those blocks highlighted in
pink correspond to groups of codons with a p-value less than 0.05 and those
regions highlighted in blue correspond to areas with a p-value greater than
0.05. Figure 1 plots the p-value of each of these codon groups. Table 5
outlines the 15 codon groups with p-values less than 0.05.
In addition to testing neighboring groups of codons, this procedure was
also applied to overlapping groups of codons. Therefore in this case, each
codon was tested in a group with the two neighboring codons on either side.
The groups of 5 codons are tested against replication capacity and the re-
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spective p-value is recorded. The procedure is identical to the procedure
described above in which a model is ﬁt using polymars and the p-value cor-
responding to the summary F-statistic is recorded. This p-value is compared
to a distribution of p-values obtained by running polymars on a permuted
dataset 5000 times. This method results in a smoother distribution as com-
pared to performing the pathway analysis on the disjoint sets of codons.
The respective p-values are plotted in Figure 2. Again, the signiﬁcant areas
closely correspond to the areas highlighted in Table 5.
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Figure 1: Neighboring Codon Groups.
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Figure 2: Overlapping Codon Groups.
4.3.1 Application of Multiple Testing
When comparing multiple pathways simultaneously, as illustrated above, one
can apply a multiple testing procedure to the ﬁnal list of marginal pathway p-
values. Multiple testing procedures such as Benjamini and Hockberg’s FDR
procedure will control E( Vn
Rn
) ≤ α, where Vn corresponds to the number of
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Table 6: Regions of Viral Strand
Model p-value
ln(RC) = 3.517− 1.218(pr43) 0.0012
ln(RC) = 3.551− 0.2904(pr43)− 0.3039(pr46)− 2.046(pr43)(pr46) 0.0014
ln(RC) = 3.517− 0.0869(pr47)− 0.4054(pr43)− 3.489(pr43)(pr47) 0.00146
false positives and Rn refers to the number of rejections. In addition other
marginal techniques can easily applied to the set of p-values.
4.4 Testing a Region of the Viral Strand
The pathway method can also be used to test sections of the viral strand.
In this speciﬁc application the univariatly signiﬁcant codons pr43, pr46, and
pr47 were tested in successively larger groups with the data adaptive regres-
sion procedure polymars. Therefore three models were built with (pr43),
(pr43, pr46), and (pr43, pr46, pr47) respectively. These positions were cho-
sen because of their proximity on the viral strand as well as their signiﬁcant
univariate signiﬁcance.
The polymars data adaptive regression technique was applied and a sum-
mary F-statistic was calculated, comparing the ﬁnal model to the model con-
taining only the intercept. The replication capacity values were permuted
and this procedure was replicated 5000 times. The ﬁnal model speciﬁc F-
statistic was compared to the 5000 F-statistics under the null hypothesis
(H0 : Y ⊥ X). A ﬁnal p-value is calculated which is recorded in Table 6.
Table 6 indicates that the three successively larger models of neighboring
codons are signiﬁcant when compared to the null model. The regression
models indicate that an interaction between either pr43 and pr46 or pr43
and pr47 decreases the replication capacity to a greater extent as compared
to a single codon mutation in position pr43, pr47 or pr46.
4.5 Testing Bivariate Models of Codons
In addition to testing neighboring sections of the viral strand, we were also
interested in applying the pathway methodology to test bivariate models of
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Table 7: Univariate Codon Signiﬁcance
Codon p-value
pr10 0.0002
pr32 0
pr43 0.0012
pr44 0.0001
pr45 0
pr54 0
pr55 0.0002
pr60 0.0355
pr71 0.001
pr73 0.024
pr82 0
rt41 0
rt67 0.0225
rt83 0.0145
rt102 0.003
rt121 0
rt184 0
rt211 0.0215
rt214 0.027
rt215 0.001
univariatly signiﬁcant codons across the viral strand. A group of 20 codons
was identiﬁed as those codons with marginal univariate p-values less than
0.05. These codons included: pr10, pr32, pr43, pr46, pr47, pr54, pr55,
pr60, pr71, pr73, pr82, rt41, rt67, rt83, rt102, rt121, rt184, rt211, rt214,
rt215. Initially a model was built for each of these positions to examine the
respective individual univariate relationship with replication capacity. An
F-statistic was obtained for the model. The replication capacity was per-
muted and the model was built 5000 times, each time recording a respective
F-statistic. For each codon position, the respective F-statistic was compared
to the null distribution of F-statistics and a corresponding p-value was cal-
culated. Table 7 outlines these univariate p-values.
In addition to these univariate models, polymars was used on all 190
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Table 8: Bivariate Models
Model p-value
ln(RC) = 3.528− 0.2021(pr10)− 0.00086(rt102)− 2.268(pr10)(rt102) 0.0001
ln(RC) = 3.551− 0.2904(pr43)− 0.3039(pr55)− 2.046(pr43)(pr55) 0.0001
ln(RC) = 3.512− 0.3751(pr43) + 0.0483(rt102)− 3.121(pr43)(rt102) 0.0002
ln(RC) = 3.572− 0.1753(pr43)− 0.2461(rt215)− 1.953(pr43)(rt215) 0.0001
ln(RC) = 3.549− 4.013(pr55)− 0.4509(rt67) + 3.999(pr55)(rt67) 0.0001
ln(RC) = 3.497− 0.5282(pr55) + 0.0399(rt102)− 2.823(pr55)(rt102) 0.0001
ln(RC) = 3.501− 0.1039(pr71) + 0.1555(rt102)− 1.543(pr71)(rt102) 0.0006
unique bivariate combinations of these 20 codons. As mentioned in the
previous example, polymars was applied to two codons at a time and an
F-statistic for the respective model was obtained. The replication capacity
measurements were then permuted and the polymars procedure was repeated
5000 times, each repetition producing an F-statistic. Finally, the model F-
statistic is compared to these 5000 null F-statistics and a respective p-value
is obtained. This procedure is individually repeated for each of the 190 pairs
of codons. We are particularly interested in the bivariate models in which
the p-value is less than the minimum of the two p-values for the univariate
models. This phenomena occurred seven times and the models and respective
p-values are illustrated in the Table 8.
The models in Table 8 show the importance of an interactive eﬀect of the
codon mutations on the outcome of viral replication. As will be discussed
in the following section, individually each of these codons is biologically im-
portant. It is therefore interesting to see the added eﬀect produced by the
combination of these mutations as compared to a single mutation alone. In
particular, the ﬁfth model containing pr55 and rt67 is interesting since the
interaction of the two mutations causes an increase in viral replication. The
other models correspond to cases where the combination of the two mutations
decrease the replication capacity.
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4.6 Biological Results
The above pathway analyses produced results that are biologically relevant
to previous studies. In this section we will examine the individual importance
of the positions mentioned in the previous sections. In particular, protease
positions pr32, pr34, pr43, pr46, pr47, pr54, pr55, pr82, and pr90, and re-
verse transcriptase positions rt41, rt184, and rt215, have been singled out
in previous research as related to replication capacity and/or antiretroviral
resistance (Birkner et al., 2004; Segal et al., 2004; Shafer et al., 2001a). The
speciﬁc mutations observed in our dataset parallel those found in the liter-
ature. For example, V pr32I, Mpr46I, Ipr54V/L/T , V pr82A/T/F/S, and
Lpr90M , correspond to protease positions in which mutations increase the
resistance to various protease inhibitors. Mutations in several of the identi-
ﬁed codons also have an impact on the replication capacity of the virus. Re-
verse transcriptase mutation at position rt41 (Mrt41L) increases azidothymi-
dine (AZT) resistance when present with Trt215Y/F . In addition, mutation
Mrt184V/I suppresses the wild-type activity of Trt215Y , thus decreasing
AZT resistance (Shafer et al., 2001a). AZT, also known as Zidovudine, is a
nucleoside reverse transcriptase inhibitor. It aﬀects HIV’s ability to replicate
by producing faulty reverse transcriptase and hence inhibiting the transcrip-
tion of RNA to DNA.
Several reverse transcriptase codon position mutations are related to an-
tiretroviral resistance and viral replication capacity (i.e. positions rt184,
rt215, rt41, rt210, rt116, rt65, rt67, and rt69) (Shafer et al., 2001b). Ex-
amples of such mutations include rt41, where Mrt41L increases AZT resis-
tance when present with a Trt215Y/F mutation. A popular codon position,
Mrt184V/I, partially suppresses the Trt215Y mediated AZT resistance. Ad-
ditionally, mutations at positions of the reverse transcriptase rt41, rt184,
rt215 among others have shown resistance to NRTIs (Shafer et al., 2001b).
Reverse transcriptase positions rt215, rt184, and rt41 have the largest re-
sistance to AZT, as compared to other RT positions. Reverse transcriptase
position rt70 mutations also causes resistance to AZT when there are amino
acid changes at Krt70R, followed by Trt215F/Y , Mrt41L, Drt67N , and
Krt219Q (Goudsmit et al., 1997).
Finally, several protease mutations in certain positions have been found
to have an impact on resistance of the virus (codons: pr54, pr53, pr46, pr47,
pr48, pr50, pr36, pr77, pr82, pr32, pr84, pr20, pr30, pr24, pr73, pr88, pr10,
pr90, pr93, pr71, pr63) (Shafer et al., 2001b). Protease positions pr10, pr46,
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pr48, pr54, pr63, pr71, pr82, pr84, and pr90 cause resistance to saquinavir
alone or in combination with AZT (Prado et al., 2002); protease positions
pr20, pr33, pr36, pr46, pr54, pr63, pr71, pr82, pr84, and pr90 cause ritonavir
resistance; protease positions pr10, pr20, pr24, pr32, pr46, pr54, pr63, pr64,
pr71, pr82, pr84, and pr90 cause resistance to indinavir; and ﬁnally protease
positions pr30, pr36, pr46, pr71, pr77, and pr84 cause resistance to nelﬁnavir.
5 Summary
This article considered a method to determine the signiﬁcance of a biolog-
ical pathway constructed with a data adaptive regression technique. This
procedure uses the permutation distribution as the null distribution and it is
shown how this distribution correctly controls the Type I error rate. Simula-
tions were presented to verify the Type-I error control as well as compare this
procedure to other currently used pathway analysis techniques. In addition,
a data analysis has been presented, which applies the pathway technique
in a variety of ways to the HIV-1 dataset. This procedure found potential
new results when examining the various pathways. The results of this pro-
cedure are biologically interesting and parallel results found in the literature
or from other statistical analyses. This procedure is an important method
to be used in the ﬁeld of computational biology to test the independence of
genetic markers and an outcome.
We present a ﬂexible procedure which can be used with both binary and
continuous independent and dependent variables. It is important to note
that, as discussed previously, the Logic Regression technique of Ruckinski
et al. (2003) is testing the null hypothesis of independence between covari-
ates and the outcome based on a logic regression ﬁt. This approach is an
appropriate method when one is dealing with binary covariates.
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Figure 3: Neighboring Codon Groups.
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